Synthesis of [99mTc]ethylenedicysteine-colchicine for evaluation of antiangiogenic effect

Angiogenesis is in part responsible for tumor growth and the development of metastasis. Radiolabeled angiongenesis inhibitors would be useful to assess tumor microvasculature density, Colchicine (COL), a potent antiangiogenic agent, is known to inhibit microtubule polymerization and cell arrest at metaphase. This study aimed to develop Tc-99m-labeled COL (EC-COL) using ethylenedicysteine (EC) as a chelator to assess tumor microvascular density, EC was conjugated to trimethylcolchicinic acid using N-hydroxysuccinimide and 1-ethyl-3-dimethylaminopropyl carbodiimide as coupling agents with a yield of 50-60%, In vivo stability was analyzed in rabbit serum at 0.5-4 h. Tissue distribution and planar imaging studies of [Tc-99m]EC-COL were evaluated in breast tumor-bearing rats at 0.5, 2 and 4 h. The data was compared to that using [Tc-99m]EC (control). The radiochemical yield of [Tc-99m]EC-COL was greater than 95%, [Tc-99m]EC-COL was stable in rabbit serum, In vivo biodistribution of [Tc-99m]EC-COL in breast tumor-bearing rats showed increased tumor-to-blood (0.52+/-0.12 to 0.72+/-0.07) and tumor-to-muscle (3.47+/-0.40 to 7.97+/-0.93) ratios as a function of time. Conversely, tumor-to-blood values showed a time-dependent decrease with [Tc-99m]EC over the same time period, Planar images confirmed that the tumors could be visualized clearly with [Tc-99m]EC-COL from 0.5 to 4 h, [Tc-99m]EC-COL may be useful to assess antiangiogenic and therapeutic effects during chemotherapy, [(C) 1999 Lippincott Williams & Wilkins.].